133 related articles for article (PubMed ID: 38008257)
21. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.
Rubinstein JC; Dinauer C; Herrick-Reynolds K; Morotti R; Callender GG; Christison-Lagay ER
J Pediatr Surg; 2019 Jan; 54(1):129-132. PubMed ID: 30361076
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of axillary lymph node metastases in invasive lobular breast carcinoma.
Deberti M; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
J Gynecol Obstet Hum Reprod; 2023 Dec; 52(10):102665. PubMed ID: 37734568
[TBL] [Abstract][Full Text] [Related]
24. Axillary Node Metastases of Medullary Thyroid Cancer: A Hallmark of Terminal Disease.
Machens A; Lorenz K; Weber F; Dralle H
Horm Metab Res; 2024 Jun; 56(6):429-434. PubMed ID: 37689057
[TBL] [Abstract][Full Text] [Related]
25. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.
van der Wal BC; Butzelaar RM; van der Meij S; Boermeester MA
Eur J Surg Oncol; 2002 Aug; 28(5):481-9. PubMed ID: 12217299
[TBL] [Abstract][Full Text] [Related]
26. An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL
Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615
[No Abstract] [Full Text] [Related]
27. Establishment and validation of a nomogram model for predicting distant metastasis in medullary thyroid carcinoma: An analysis of the SEER database based on the AJCC 8th TNM staging system.
Chen Z; Mao Y; You T; Chen G
Front Endocrinol (Lausanne); 2023; 14():1119656. PubMed ID: 36875492
[TBL] [Abstract][Full Text] [Related]
28. Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients.
Li Destri G; Barchitta M; Pesce A; Latteri S; Bosco D; Di Cataldo A; Agodi A; Puleo S
J Invest Surg; 2019 Jan; 32(1):1-7. PubMed ID: 28972442
[TBL] [Abstract][Full Text] [Related]
29. High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor Prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary Thyroid Cancer.
Chen L; Sun W; Qian K; Guo K; Sun T; Wu YI; Wang Z
Endocr Pract; 2020 Jul; 26(7):738-747. PubMed ID: 33471642
[TBL] [Abstract][Full Text] [Related]
30. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
Singh D; Mandal A
Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
[TBL] [Abstract][Full Text] [Related]
32. Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma.
Ma T; Cui J; Shi P; Liang M; Song W; Zhang X; Wang L; Shi Y
Front Endocrinol (Lausanne); 2023; 14():1158826. PubMed ID: 37790606
[TBL] [Abstract][Full Text] [Related]
33. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013
[TBL] [Abstract][Full Text] [Related]
34. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Machens A; Lorenz K; Weber F; Dralle H
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
[TBL] [Abstract][Full Text] [Related]
35. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.
Esfandiari NH; Hughes DT; Yin H; Banerjee M; Haymart MR
J Clin Endocrinol Metab; 2014 Feb; 99(2):448-54. PubMed ID: 24276457
[TBL] [Abstract][Full Text] [Related]
36. Prediction of lateral neck lymph node metastasis according to preoperative calcitonin level and tumor size for medullary thyroid carcinoma.
Bae SY; Jung SP; Choe JH; Kim JS; Kim JH
Kaohsiung J Med Sci; 2019 Dec; 35(12):772-777. PubMed ID: 31483088
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Performance of Alternative Lymph Node Classification Systems for Patients with Medullary Thyroid Cancer: A Single Center Cohort Study.
Prassas D; Kounnamas A; Cupisti K; Schott M; Knoefel WT; Krieg A
Ann Surg Oncol; 2022 Apr; 29(4):2561-2569. PubMed ID: 34890024
[TBL] [Abstract][Full Text] [Related]
38. Combined role of lymph node ratio and serum thyroglobulin levels in predicting prognosis of papillary thyroid carcinoma.
Jeon S; Kwon SY; Ryu YJ; Kang SR; Yoo SW; Cho SG; Kim J; Song HC; Sohn SJ; Bom HS; Min JJ
Nucl Med Commun; 2020 Aug; 41(8):733-739. PubMed ID: 32427697
[TBL] [Abstract][Full Text] [Related]
39. Lymph node ratio is superior to AJCC N stage for predicting recurrence in papillary thyroid carcinoma.
Parvathareddy SK; Siraj AK; Qadri Z; Ahmed SO; DeVera F; Al-Sobhi S; Al-Dayel F; Al-Kuraya KS
Endocr Connect; 2022 Feb; 11(2):. PubMed ID: 35044932
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathological analysis of superior mediastinal lymph node metastases in medullary thyroid carcinoma].
He YY; Chen YT; Wang J; Chen MQ; Zhu YM; Ni S; Liu SY
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):82-87. PubMed ID: 36709124
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]